SOFT TISSUE SARCOMA ADULT
Clinical trials for SOFT TISSUE SARCOMA ADULT explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMA ADULT trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMA ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Proton beams take aim at inoperable sarcomas in new norwegian trial
Disease control Recruiting nowThis study tests whether a higher dose of proton radiation can better control soft tissue sarcomas that cannot be surgically removed. About 40 adults in Norway will receive radiation over 4 weeks, with the highest dose focused on the tumor center. The main goal is to see if the t…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
New drug combo shows promise for Hard-to-Treat sarcomas
Disease control Recruiting nowThis study tests a combination of two drugs, pembrolizumab and cabozantinib, in people with advanced sarcomas that have not responded to standard treatments. The goal is to see if this combo can stop or shrink tumors for at least 6 months. About 119 adults with specific sarcoma t…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated May 26, 2026 12:01 UTC
-
New study aims to cut radiation side effects for sarcoma patients
Disease control Recruiting nowThis study tests whether giving a shorter course of radiation (3 weeks instead of longer) before surgery for soft tissue sarcoma can reduce long-term side effects. Each patient's treatment is personalized by choosing between proton or standard X-ray radiation. The study will enro…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New combo therapy aims to halt rare sarcomas
Disease control Recruiting nowThis study tests whether adding an experimental immune-boosting drug (retifanlimab) to standard chemotherapy (gemcitabine and docetaxel) can help control advanced soft tissue sarcoma that has spread or cannot be removed by surgery. About 98 adults with this rare cancer will recei…
Matched conditions: SOFT TISSUE SARCOMA ADULT
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
800-Patient study aims to tailor sarcoma treatment with precision
Knowledge-focused Recruiting nowThis study is gathering tissue samples and medical information from 800 people with high-risk soft tissue sarcomas. The goal is to learn how to personalize chemotherapy before surgery, using genetic and protein profiles. Participants either receive standard chemo plus surgery or …
Matched conditions: SOFT TISSUE SARCOMA ADULT
Sponsor: Royal Marsden NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC